ZFP92 is a transcription factor that may be influenced by a variety of intracellular signaling molecules and pathways. The activation of adenylate cyclase, for instance, elevates intracellular cAMP levels, which are known to enhance the activity of transcription factors through phosphorylation by specific kinases such as cAMP response element-binding protein (CREB). This phosphorylation event can lead to increased DNA-binding activity of transcription factors like ZFP92, which in turn affects gene expression patterns critical for cellular function. Similarly, the activation of protein kinase C (PKC) can lead to the phosphorylation of proteins that interact with ZFP92, potentially affecting its ability to bind DNA and regulate gene expression. Additionally, intracellular calcium plays a pivotal role in cellular signaling, and its increase can activate calcium-dependent kinases that modulate the activity of transcription factors such as ZFP92.
Moreover, the inhibition of certain signal transduction pathways can lead to compensatory feedback mechanisms that indirectly activate ZFP92. For example, the inhibition of the PI3K/AKT pathway could lead to such compensatory feedback, which may include the activation of ZFP92. The alteration of phosphorylation states through the inhibition of p38 MAPK or MEK can also modulate the regulation of ZFP92 activity. Furthermore, the inhibition of protein tyrosine phosphatases or protein phosphatases such as PP1 and PP2A can increase the phosphorylation state of proteins that regulate ZFP92, leading to its enhanced function. The modulation of ZFP92 activity can also be influenced by the inhibition of GSK-3, which is implicated in the Wnt signaling pathway. This inhibition could affect ZFP92 activity indirectly through β-catenin stabilization. Lastly, the elevation of cAMP levels by β-adrenergic receptor activators or the demethylation of the ZFP92 promoter region are additional mechanisms by which ZFP92 activity could be upregulated within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising intracellular cAMP levels, which may enhance ZFP92 transcription factor activity by cAMP response element-binding protein (CREB) phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) which could lead to phosphorylation of proteins that interact with ZFP92, affecting its DNA-binding activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which could activate calcium-dependent kinases that modulate ZFP92 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of the PI3K/AKT pathway, which could lead to compensatory feedback mechanisms that activate ZFP92. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially altering the phosphorylation state of proteins that regulate ZFP92 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, potentially modulating MAPK/ERK signaling and affecting downstream regulation of ZFP92. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits protein tyrosine phosphatases, potentially increasing phosphorylation states that could enhance ZFP92 function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, potentially leading to the increased phosphorylation and subsequent activation of proteins that interact with ZFP92. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), potentially affecting Wnt signaling and modulating ZFP92 activity through β-catenin stabilization. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium, potentially activating calcium-dependent kinases that influence ZFP92 activity. | ||||||